Anne R Bass Selected Research

Anne R Bass Research Topics

Disease

12	Neoplasms (Cancer) 01/2022 - 09/2007
8	Arthritis (Polyarthritis) 01/2022 - 12/2010
6	Melanoma (Melanoma, Malignant) 01/2022 - 10/2019
6	COVID-19 10/2021 - 10/2020
6	Rheumatoid Arthritis 01/2021 - 02/2007
4	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 01/2021
4	Infections 01/2021 - 01/2018
4	Venous Thromboembolism 01/2021 - 04/2015
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 02/2015
2	Polymyalgia Rheumatica (Rhizomelic Pseudopolyarthritis) 01/2022 - 01/2019
2	Osteoarthritis 01/2021 - 01/2019
2	Eosinophilic Fasciitis 01/2020 - 10/2019
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2019 - 01/2017
1	Autoimmune Diseases (Autoimmune Disease) 01/2022
1	Colitis 01/2022
1	Hepatitis 01/2022
1	Myocarditis (Carditis) 01/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Joint Diseases (Joint Disease) 01/2021
1	Spondylarthropathies 01/2021
1	Thrombotic Microangiopathies 12/2020
1	Virus Diseases (Viral Diseases) 10/2020
1	Surgical Wound Infection 01/2019
1	Subacute Sclerosing Panencephalitis (SSPE) 04/2018
1	Inflammation (Inflammations) 02/2018
1	Psoriatic Arthritis 01/2018
1	Ankylosing Spondylitis 01/2018
1	Hemorrhage 01/2017
1	Stroke (Strokes) 04/2015
1	Atrial Fibrillation 04/2015
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2015
1	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2011
1	Gout 12/2010
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 09/2007
1	Oncogenic osteomalacia 09/2007
1	Osteomalacia 09/2007

Drug/Important Bio-Agent (IBA)

13	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2019
4	Antirheumatic Agents (DMARD)IBA 01/2022 - 01/2019
4	GlucocorticoidsIBA 01/2021 - 01/2018
3	Rheumatoid FactorIBA 01/2022 - 10/2020
3	VaccinesIBA 10/2021 - 01/2021
3	LigandsIBA 04/2020 - 10/2019
3	Programmed Cell Death 1 ReceptorIBA 04/2020 - 10/2019
2	AutoantibodiesIBA 01/2022 - 01/2022
2	cyclic citrullinated peptideIBA 01/2022 - 10/2020
2	SteroidsIBA 01/2022 - 10/2020
2	Anti-Citrullinated Protein AntibodiesIBA 01/2022 - 01/2022
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2019
2	Antinuclear AntibodiesIBA 01/2022 - 01/2022
2	Immunosuppressive Agents (Immunosuppressants)IBA 10/2020 - 01/2018
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2019
2	Warfarin (Coumadin)FDA LinkGeneric 01/2019 - 01/2017
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	AntibodiesIBA 01/2022
1	AutoantigensIBA 01/2022
1	Cholinergic ReceptorsIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	atezolizumabIBA 12/2021
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Complement System Proteins (Complement)IBA 12/2020
1	Prednisone (Sone)FDA LinkGeneric 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 10/2020
1	Biological ProductsIBA 10/2020
1	B7-H1 AntigenIBA 10/2020
1	Apoptosis Regulatory ProteinsIBA 04/2020
1	Monoclonal AntibodiesIBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	cobimetinibIBA 01/2019
1	NivolumabIBA 01/2019
1	IpilimumabIBA 01/2019
1	durvalumabIBA 01/2019
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 04/2018
1	Atorvastatin (Lipitor)FDA Link 02/2018
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2018
1	edoxabanIBA 04/2015
1	N(4)-oleylcytosine arabinosideIBA 04/2015
1	RivaroxabanIBA 04/2015
1	AnticoagulantsIBA 04/2015
1	apixabanIBA 04/2015
1	Pharmaceutical PreparationsIBA 04/2015
1	Dabigatran FDA Link 04/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2011
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2010
1	Uric Acid (Urate)IBA 12/2010
1	Vitamin D FDA LinkGeneric 09/2007
1	Infliximab (Remicade)FDA Link 02/2007

Therapy/Procedure

7	Therapeutics 01/2022 - 02/2018
4	Knee Replacement Arthroplasty (Total Knee Replacement) 01/2021 - 01/2017
3	Immunotherapy 10/2020 - 12/2018
3	Arthroplasty 01/2019 - 02/2015
2	Orthopedic Procedures 02/2018 - 04/2015
1	Injections 01/2022
1	Biological Therapy 01/2019
1	Contraindications 12/2010